| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0079-6123(08)60646-9 |
| P698 | PubMed publication ID | 2878466 |
| P50 | author | Tomas Hökfelt | Q2440397 |
| P2093 | author name string | Hansen S | |
| Lundberg JM | |||
| Fried G | |||
| Holets V | |||
| Skirboll L | |||
| P2860 | cites work | Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons | Q24561505 |
| Distinct cholecystokinin receptors in brain and pancreas | Q28366068 | ||
| Demonstration of biological activity of brain gastrin-like peptidic material in the human: its relationship with the COOH-terminal octapeptide of cholecystokinin | Q33958576 | ||
| Serotonin and substance P coexist in neurons of the rat's central nervous system | Q33970059 | ||
| Neuropeptide Y: complete amino acid sequence of the brain peptide | Q34056649 | ||
| Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain | Q34322648 | ||
| Cholecystokinin and its COOH-terminal octapeptide in the pig brain | Q35038453 | ||
| Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. | Q36358114 | ||
| Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists | Q36375033 | ||
| Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain | Q37313218 | ||
| Direct hypothalamo-autonomic connections | Q39407341 | ||
| Immunochemical evidence of cholecystokinin-like peptides in brain | Q39414097 | ||
| The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat | Q71335176 | ||
| Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection | Q71474792 | ||
| Polypeptide with Broad Biological Activity: Isolation from Small Intestine | Q71521100 | ||
| Immunohistochemical localization of thyrotropin-releasing hormone in the rat hypothalamus and pituitary | Q71605918 | ||
| Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system | Q71673006 | ||
| Thyrotropin releasing hormone, somatostatin, and enkephalin: distribution studies using immunohistochemical techniques | Q72422336 | ||
| Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons | Q72520484 | ||
| Coexistence of glutamic acid decarboxylase- and somatostatin-like immunoreactivity in neurons of the feline nucleus reticularis thalami | Q72553379 | ||
| Ceruletide resembles antipsychotics in rats and schizophrenic patients. Preliminary report | Q72596726 | ||
| Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5,7-dihydroxytryptamine injection | Q72637262 | ||
| Immunohistochemical support for three putative transmitters in one neuron: Coexistence of 5-hydroxytryptamine, substance p- and thyrotropin releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord | Q72650617 | ||
| Substance P, but not TRH, modulates the 5-HT autoreceptor in ventral lumbar spinal cord | Q72654050 | ||
| The effects of 5-hydroxytryptamine-depleting drugs on peptides in the ventral spinal cord | Q72659218 | ||
| Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens | Q72690567 | ||
| Substance P-immunoreactive and serotonin-containing neurones in the ventral brainstem of the cat | Q72702920 | ||
| Behavioural responses induced by intrathecal injection of 5-hydroxytryptamine in mice are inhibited by a substance P antagonist, D-Pro2, D-Trp7,9-substance P | Q72723479 | ||
| Cholecystokinin Receptors in the Brain: Characterization and Distribution | Q72851367 | ||
| Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in rats | Q72895371 | ||
| Characterization of Receptors for Cholecystokinin and Related Peptides in Mouse Cerebral Cortex | Q72903203 | ||
| Fuorescent retrograde neuronal labeling in rat by means of substances binding specifically to adenine-thymine rich DNA | Q39555848 | ||
| Peptidergic neurones | Q40097706 | ||
| An efficient method of antibody elution for the successive or simultaneous localization of two antigens by immunocytochemistry | Q40152765 | ||
| Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide | Q40240056 | ||
| Immunohistochemical evidence for a neurophysin-containing autonomic pathway arising in the paraventricular nucleus of the hypothalamus | Q40649216 | ||
| Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system | Q40936846 | ||
| Distribution of substance P-like immunoreactivity in the central nervous system of the rat—I. Cell bodies and nerve terminals | Q40983250 | ||
| Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system | Q41003757 | ||
| Distribution of gastrin and CCK-like peptides in rat brain. An immunocytochemical study | Q41019908 | ||
| Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: Evidence from combined immunohistochemistry and acetylcholinesterase staining | Q41136899 | ||
| Cholecystokinin appears to have antipsychotic properties | Q41609649 | ||
| Structure of the Porcine Vasoactive Intestinal Octacosapeptide. The Amino-Acid Sequence. Use of Kallikrein in Its Determination | Q42235815 | ||
| Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam | Q42246548 | ||
| Substance P in the ascending cholinergic reticular system | Q42449376 | ||
| Autoradiographic localization of cholecystokinin receptors in rodent brain | Q42452814 | ||
| Cholecystokinin receptors in brain: Effects of obesity, drug treatment, and lesions | Q45305739 | ||
| Autoradiographic localization of CCK receptors in guinea pig brain | Q46332399 | ||
| Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function | Q46624904 | ||
| Cholecystokinin receptor binding in brain and pancreas: regulation of pancreatic binding by cyclic and acyclic guanine nucleotides | Q46918336 | ||
| Immunohistochemical localizatio of protein components of catecholamine storage vesicles | Q47679920 | ||
| Chronic catheterization of the spinal subarachnoid space | Q48344815 | ||
| Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor | Q48395090 | ||
| New peptide in the vertebrate CNS reacting with antigastrin antibodies | Q48435369 | ||
| Thyrotropin releasing hormone (TRH)-containing nerve terminals in certain brain stem nuclei and in the spinal cord | Q48440633 | ||
| A method for specific transmitter identification of retrogradely labeled neurons: immunofluorescence combined with fluorescence tracing | Q48599947 | ||
| Spinal monoaminergic modulation of masculine copulatory behavior in the rat. | Q48657969 | ||
| Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons | Q48668517 | ||
| Supersensitivity to the respiratory stimulatory effect of TRH in 5,7-dihydroxytryptamine-treated rats | Q48681454 | ||
| Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: Evidence for the existence of storage sites containing the two transmitters | Q48682153 | ||
| Micromolar substance P reduces spinal receptor binding for thyrotropin-releasing hormone — possible relevance to neuropeptide coexistence? | Q48703354 | ||
| Evidence that spinal cord thyrotropin-releasing hormone is independent oft he paraventricular nucleus | Q48703717 | ||
| Descending serotonergic, peptidergic and cholinergic pathways from the raphe nuclei: A multiple transmitter complex | Q48704979 | ||
| Peptides, the limbic lobe and schizophrenia | Q48705026 | ||
| The effects of cholecystokinin on dopaminergic mechanisms in rat striatum | Q48723280 | ||
| Comparative effects of neonatal hypothyroidism and euthyroidism on TRH and substance P content of lumbar spinal cord in saline and PCPA-treated rats | Q48723398 | ||
| In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents | Q48738164 | ||
| CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors | Q48750529 | ||
| Studies of the uptake of3H-GABA and [3H]glycine in slices and homogenates of rat brain and spinal cord by electron microscopic autoradiography | Q48754157 | ||
| Perturbation of Rat Brain Serotonergic Systems Results in an Inverse Relation Between Substance P and Serotonin Concentrations Measured in Discrete Nuclei | Q48754566 | ||
| Localization of enkephalin-like immunoreactivity in acetylcholinesterase-positive cells in the guinea-pig lateral superior olivary complex that project to the cochlea | Q48788729 | ||
| Influence of the route of administration on thyrotropin-releasing hormone concentration in the mouse brain | Q48794628 | ||
| Modulation of CNS dopamine receptors by peptides | Q48853876 | ||
| Effect of 6-hydroxydopamine lesions of the medial forebrain bundle on the distribution of cholecystokinin in rat forebrain | Q48860264 | ||
| The distribution of serotonin, met-enkephalin and beta-lipotropin-like immunoreactivity in neuronal perikarya of the cat brainstem | Q48942874 | ||
| Evidence for the presence of enkephalin in catecholaminergic neurones of cat locus coeruleus | Q48942896 | ||
| Modulation of [3H]-dopamine binding by cholecystokinin octapeptide (CCK-8) | Q48951188 | ||
| Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide | Q48955294 | ||
| Origin of the cholecystokinin-containing fibers in the rat caudatoputamen | Q49019094 | ||
| Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats | Q49022819 | ||
| The effects of monoamine neurotoxins on peptides in the rat spinal cord | Q49119355 | ||
| Modulation by cholecystokinins of3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites | Q49149747 | ||
| Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus | Q51848548 | ||
| Inverse relation of substance P-like immunoreactivity in dorsal raphe nucleus to serotonin levels in pons-medulla following administration of cocaine and 5-hydroxytryptophan | Q51867630 | ||
| Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol | Q51868868 | ||
| Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders. | Q52093070 | ||
| Behavioral and neurophysiological evidence for a facilatory interaction between co-existing transmitters: cholecystokinin and dopamine. | Q52093079 | ||
| Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin. | Q54489353 | ||
| Changes in brain cholecystokinin octapeptide following lesions of the medial forebrain bundle | Q54495436 | ||
| Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to α-adrenoceptor blockade | Q54509411 | ||
| Spinal Reflexes and Monoamine Liberation | Q59061630 | ||
| Immunoreactive substance P and serotonin present in the same dense-core vesicles | Q59075533 | ||
| Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland | Q59077523 | ||
| Evidence for coexistence of dopamine and CCK in meso-limbic neurones | Q59099123 | ||
| Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides | Q60050311 | ||
| Reduction of substance P levels in the ventral cervical spinal cord of the rat after intracisternal 5,7-dihydroxytryptamine injection | Q63608786 | ||
| Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat | Q64217912 | ||
| Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons | Q64217913 | ||
| 5-Hydroxytryptamine-thyrotropin releasing hormone interactions in the spinal cord: Effects on parameters of sexual behaviour in the male rat | Q64217917 | ||
| Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata | Q64217918 | ||
| A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing | Q67270148 | ||
| Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat | Q67297699 | ||
| Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens | Q69801579 | ||
| Influence of cholecystokinin on central monoaminergic pathways | Q70155301 | ||
| A simple method of reducing the fading of immunofluorescence during microscopy | Q70161232 | ||
| Cholecystokinin peptides in vitro modulate the characteristics of the striatal3H-N-propylnorapomorphine sites | Q70167390 | ||
| Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors | Q70179951 | ||
| In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin | Q70200819 | ||
| Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand | Q70202430 | ||
| Antipsychotic effects of ceruletide (caerulein) on chronic schizophrenia | Q70223835 | ||
| Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine | Q70251591 | ||
| CCK nerve terminals in the rat striatal and limbic areas originate partly in the brain stem and partly in telencephalic structures | Q70428894 | ||
| Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens | Q70814119 | ||
| Subcellular fractionation of cat submandibular gland: Comparative studies on the distribution of acetylcholine and vasoactive intestinal polypeptide (VIP) | Q70920444 | ||
| Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons | Q71036842 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 115-137 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | Progress in Brain Research | Q15800382 |
| P1476 | title | Neurons with multiple messengers--distribution and possible functional significance | |
| P478 | volume | 65 |
| Q48449886 | Circadian rhythm of the endopeptidase 22.19 (EC 3.4.22.19) in the rat brain |
| Q43330998 | Differential effects of intrathecal thyrotropin-releasing hormone (TRH) on perineal reflexes in male rats |
| Q38224475 | Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds |
| Q44113323 | Intracellular labeling of neurons in the medial accessory olive of the cat: III. Ultrastructure of axon hillock and initial segment and their GABAergic innervation |
| Q44532417 | Peptidergic modulation of intrathalamic circuit activity in vitro: actions of cholecystokinin. |
| Q38656900 | The neuroendocrine system of the gut. |
| Q69087840 | Ultrastructural study of the GABAergic, cerebellar, and mesodiencephalic innervation of the cat medial accessory olive: anterograde tracing combined with immunocytochemistry |
Search more.